Evidence map›Paper›PMID 21788373›Full record

Trial reportNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2012

The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population.

Jaroslav A Hubacek, Ondrej Viklicky, Dana Dlouha, Silvie Bloudickova, Ruzena Kubinova, Anne Peasey, Hynek Pikhart, Vera Adamkova, Irena Brabcova, Eva Pokorna and 1 more

Open access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Association between FTO polymorphism and COVID-19 mortality among older adults: A population-based cohort study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Smooth muscle cell FTO regulates contractile function.American journal of physiology. Heart and circulatory physiology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jaroslav A HubacekInstitute for Clinical and Experimental Medicine, Prague, Czech Republic.
Ondrej Viklicky
Dana Dlouha
Silvie Bloudickova
Ruzena Kubinova
Anne Peasey
Hynek Pikhart
Vera Adamkova
Irena Brabcova
Eva Pokorna
Martin Bobak
Institute of Clinical and Experimental Medicine · CZUniversity College London · GBCentre of Civil Engineering (Czechia) · CZNational Institute of Public Health · CZ

Funding

Socio-economic status and heterogeneity in agingR01AG013196 · NIA · UNIVERSITY OF LONDON INST OF NEUROLOGY · PI MARMOT, MICHAEL G, SINGH-MANOUX, ARCHANA · 1996 to 2013
$3.5M
Health disparities and agingin societies in transitionR01AG023522 · NIA · UNIVERSITY COLLEGE LONDON · PI MARMOT, MICHAEL G · 2004 to 2008
$2.2M
Injury Mechanisms and Related ResponsesT32NR007958 · NINR · UNIVERSITY OF ARIZONA · PI MOORE, IDA MARIE · 2002 to 2006
$835k
NIA NIH HHS R01 AG013196NIA NIH HHS R01 AG023522NIA NIH HHS R01 AG23522NINR NIH HHS T32 NR007958Wellcome TrustWellcome Trust WT081081
6 · The paper itself

Abstract

backgroundGenome-wide association studies identified the FTO (fat mass and obesity gene) gene as an important determinant of body weight. More recently, the FTO gene was reported to be associated with other outcomes, including major risk factors for chronic kidney disease (CKD). We investigated the role of this gene in the risk of end-stage renal disease (ESRD) caused by CKD.

methodsWe conducted two large population-based case-control studies of ESRD. Study 1 compared 984 haemodialysed patients with ESRD with 2501 participants in the Czech post-MONICA study; Study 2 compared 1188 patients included in a kidney transplantation programme for ESRD with 6681 participants in the Czech HAPIEE study. The frequencies of the FTO rs17817449 single nucleotide polymorphism genotype were compared between cases and controls.

resultsThe FTO rs17817449 genotype was significantly associated with CKD in both studies (P-values 0.00004 and 0.006, respectively). In the pooled data, the odds ratios of CKD for GG and GT, versus TT genotype, were 1.37 (95% confidence interval 1.20-1.56) and 1.17 (1.05-1.31), respectively (P for trend <0.0001). Among haemodialysed and kidney transplant patients, the onset of ESRD in GG homozygotes was 3.3 (P = 0.012) and 2.5 (P = 0.032) years, respectively, earlier than in TT homozygotes.

conclusionsThese two large independent case-control studies in the general population found robust associations between the FTO rs17817449 polymorphism and the ESRD. The results suggest that the morbidities associated with the FTO gene include CKD.

Indexed as

AdultAgedAge of OnsetAlpha-Ketoglutarate-Dependent Dioxygenase FTOBody Mass IndexCase-Control StudiesCzech RepublicDNAFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansKidney Failure, ChronicMaleMiddle AgedAlpha-Ketoglutarate-Dependent Dioxygenase FTODNAFTO protein, humanProteins

Identifiers

PMID21788373
PMCPMC3289895
OpenAlexW2154217384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.